Название

Название

Aim. To assess the efficacy of FLAG/FLAG-Ida regimen and to identify factors that influence remission, duration of disease-free survival (DFS) and overall survival (OS) of patients with relapsed/refractory acute myeloid leukemia (AML). Materials & Methods. The trial included 54 patients (28 men...

Full description

Bibliographic Details
Main Authors: IG Budaeva, EG Ovsyannikova, EN Goryunova, OV Kulemina, DV Zaitsev, DV Motorin, RSh Badaev, DB Zammoeva, VV Ivanov, KV Bogdanov, OS Pisotskaya, YuV Mirolyubova, TS Nikulina, YuA Alekseeva, AYu Zaritskey, LL Girshova
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2019-05-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
acute myeloid leukemia
relapse
refractoriness
flag and flag-ida regimens
Online Access: http://bloodjournal.ru/wp-content/uploads/2019/06/7.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2019/06/7.pdf

Similar Items